Rapid progression of fibrosing alveolitis and thyrotoxicosis after antithymocyte globulin therapy for aplastic anemia.
Ann Hematol
; 71(1): 49-51, 1995 Jul.
Article
em En
| MEDLINE
| ID: mdl-7632818
ABSTRACT
Antithymocyte globulin (ATG) therapy is an established form of treatment for aplastic anaemia and has also been used as prophylaxis against graft rejection of bone marrow and renal allografts. Administration of ATG preparations has been associated with many mild clinical reactions, as have other forms of immunomodulatory therapy. However, serious adverse effects appear to be rare. We report a case of rapidly progressive fibrosing alveolitis and thyrotoxicosis in relation to ATG therapy, highlighting its potential toxicity and emphasising that its administration should be undertaken by experienced physicians in specialised centres.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Fibrose Pulmonar
/
Tireotoxicose
/
Anemia Aplástica
/
Soro Antilinfocitário
Limite:
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Ann Hematol
Assunto da revista:
HEMATOLOGIA
Ano de publicação:
1995
Tipo de documento:
Article
País de afiliação:
Reino Unido